HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

N-(4-(1H-Pyrazol-4-yl)phenyl)-2,3-dihydro-1,4-benzodioxine-2-carboxamide

HCID 25093233
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1072906-02-5
Standard SMILES
O=C(Nc1ccc(-c2cn[nH]c2)cc1)C1COc2ccccc2O1
InChIKey
MCQBNMPALTYSES-UHFFFAOYSA-N
Molecular formula
C18H15N3O3
Average molar mass
321.3 g/mol
Monoisotopic mass
321.11134135

Names & identifiers

Preferred name
N-(4-(1H-Pyrazol-4-yl)phenyl)-2,3-dihydro-1,4-benzodioxine-2-carboxamide
IUPAC
N-[4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide
English name
Rho Kinase Inhibitor V
Molecular formula
C18H15N3O3
Molecular weight
321.33

Names & synonyms

1072906-02-5N-[4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamideDTXSID90648692N-(4-(1H-Pyrazol-4-yl)phenyl)-2,3-dihydro-1,4-benzodioxine-2-carboxamideRefChem:1091214DTXCID80599442Rho Kinase Inhibitor VN-[4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamideCHEMBL519123N-(4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamideHMS3229N11pyrazole-phenyl, 3
Show more names
Rho Kinase Inhibitor V - CAS 1072906-02-5 - Calbiochem1,4-Benzodioxin-2-carboxamide, 2,3-dihydro-N-[4-(1H-pyrazol-4-yl)phenyl]-
SCHEMBL1987209SCHEMBL29431932BDBM25472

Database identifiers

CAS
1072906-02-5
PubChem CID
25093233
DTXSID

Properties

Computed structural propertiesFilling in

XLogP
2.5
Topological polar surface area
76.2 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
3
Heavy atoms
24
Formal charge
0
Complexity
439

Physicochemical properties

Boiling point
638.4 · 638.4±55.0 °C(Predicted)
Density
1.374 · 1.374±0.06 g/cm3(Predicted)
storage temp.
2 C · +2C to +8C
solubility
2 mg/mLDMSO: · ethanol: 2mg/mLDMSO: 50mg/mL
form
Light beige solid
pka
12.53 · 12.53±0.70(Predicted)
color
light beige
InChI
1S/C18H15N3O3/c22-18(17-11-23-15-3-1-2-4-16(15)24-17)21-14-7-5-12(6-8-14)13-9-19-20-10-13/h1-10,17H,11H2,(H,19,20)(H,21,22)
InChIKey
MCQBNMPALTYSES-UHFFFAOYSA-N
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
Storage Class
11 - Combustible Solids

Chemistry & industry

Applications · 2 items

UsesFeng, Y., et al. 2008. J. Med. Chem.51, 6642.A cell-permeable pyrazolyl carboxamide compound that acts as a potent, ATP-binding pocket-targeting inhibitor of ROCK-II (IC50 = 1.5 nM) and effectively inhibits the myosin light chain 2 phosphorylation on Thr18/Ser19 in A7r5 cells (IC50 = 72 nM). It afftects the activities of PKA, MRCK, Akt1 (IC50 = 0.186, 1.19, and 1.41 µM, respectively) and CYP-450 enzymes (% inhibition of 2C9/2D6/3A4/1A2 at 10 µM = 87/40/1/20, respectively) only at much higher concentrations.

General DescriptionA cell-permeable pyrazolyl carboxamide compound that acts as a potent, ATP-binding pocket-targeting inhibitor of ROCK-II (IC50 = 1.5 nM) and effectively inhibits the myosin light chain 2 phosphorylation on Thr18/Ser19 in A7r5 cells (IC50 = 72 nM). It afftects the activities of PKA, MRCK, Akt1 (IC50 = 0.186, 1.19, and 1.41 μM, respectively) and CYP-450 enzymes (% inhibition of 2C9/2D6/3A4/1A2 at 10 μM = 87/40/1/20, respectively) only at much higher concentrations.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
DTXSID90648692
ChEMBL
CHEMBL519123